Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd (SHE:002864)
29.69
-0.12 (-0.40%)
Jul 18, 2025, 3:04 PM CST
SHE:002864 Revenue
Shaanxi Panlong Pharmaceutical Group Limited By Share had revenue of 250.21M CNY in the quarter ending March 31, 2025, with 19.08% growth. This brings the company's revenue in the last twelve months to 1.01B, up 5.04% year-over-year. In the year 2024, Shaanxi Panlong Pharmaceutical Group Limited By Share had annual revenue of 973.86M, down -0.71%.
Revenue (ttm)
1.01B
Revenue Growth
+5.04%
P/S Ratio
3.10
Revenue / Employee
1.09M
Employees
933
Market Cap
3.14B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 973.86M | -6.96M | -0.71% |
Dec 31, 2023 | 980.83M | 6.53M | 0.67% |
Jan 1, 2023 | 974.29M | 86.81M | 9.78% |
Jan 1, 2022 | 887.48M | 217.17M | 32.40% |
Dec 31, 2020 | 670.31M | 59.68M | 9.77% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 39.59B |
Sichuan Biokin Pharmaceutical | 5.82B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Aier Eye Hospital Group | 21.81B |
Shanghai United Imaging Healthcare | 10.43B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |